What We Are
Science You Can Rely On. Evidence You Can Act On
Our History
Founded in 2024, Lumina RWE was established to meet the growing demand for scientifically rigorous real-world evidence in healthcare technology. From the beginning, we have focused on bridging the gap between controlled clinical trials and the realities of clinical practice. Our methodology enables the generating of strong, defensible, reproducible evidence that can be relied and acted on by scientific review boards of the FDA, journal editors, peer reviewers, Value Analysis Committees, etc.Through strategic collaborations with biopharma, medical device innovators, and healthcare stakeholders, Lumina RWE has positioned itself as a trusted scientific partner, delivering evidence that informs regulatory approval, payer adoption, and clinical decision-making.
Industries Served
Lumina RWE provides tailored evidence solutions for the biopharmaceutical and medical device industries, supporting clients at every stage of the post-market life cycle. From study design and regulatory-ready RWE submissions to health economics, outcomes research, and post-market safety monitoring, we ensure that evidence is not only scientifically valid but also strategically aligned with regulatory and payer requirements. By integrating diverse real-world data sources and applying validated methodologies, we enable our partners to demonstrate safety, effectiveness, and value in ways that resonate with clinicians, regulators, and payers alike.
At Lumina RWE, everything we do is centered on improving patient outcomes. We understand that behind every dataset is a person, a family, and a story. That’s why our mission is to ensure that new therapies and medical technologies are evaluated not only for their scientific rigor but also for their real-world impact on patients’ lives. We focus on conditions that are complex, urgent, and often life-changing from chronic wounds to severe infections and critical injuries. By studying how treatments perform outside of controlled clinical trials, we provide healthcare providers and innovators with the clarity they need to understand what works best in real-world settings.
Our commitment is simple: to bring clarity, credibility, and compassion into the process of advancing healthcare solutions ensuring that patients can trust the care they receive is backed by rigorous, meaningful evidence.
Therapeutic Focus
Lumina RWE has developed deep expertise in therapeutic areas where robust real-world evidence can directly influence patient outcomes and technology adoption. Our core focus lies in wound care, regenerative medicine, HBOT and podiatry just to name a few. By leveraging diverse real-world datasets and rigorous analytical methods, we produce evidence that supports both regulatory and clinical acceptance, ensuring new technologies and therapies reach the patients who need them most.
For Clinicians
At Lumina RWE, we recognize that evidence must be more than regulatory submissions; it must translate into meaningful insights for physicians and their patients. Our work focuses on conditions where real-world complexity challenges traditional clinical trials. By analyzing diverse data sources from electronic health records and registries to patient-reported outcomes we generate findings that reflect the realities you see in practice, not just idealized trial populations.
Our studies emphasize outcomes that matter to clinicians. Every analysis is designed with transparency and reproducibility in mind, and we actively seek alignment with academic collaborators and medical societies to ensure credibility and clinical utility. Whether you are evaluating new therapeutic technologies, refining treatment pathways, or supporting evidence-based practice, Lumina RWE provides data-driven insights that strengthen decision-making and ultimately improve patient outcomes.